Literature DB >> 26018533

Gamma Interferon Assays Used in the Diagnosis of Tuberculosis.

Rebecca T Horvat1.   

Abstract

Tuberculosis (TB) is an ancient disease that has infected humans for thousands of years. However, despite diagnostic tests that detect the disease and effective therapy, there are still millions of people worldwide who are infected with TB. The first TB test used to detect infected patients was a skin test that identifies individuals actively infected with TB. This test used a mix of proteins from culture filtrates of the bacteria Mycobacterium tuberculosis. Recently, two new diagnostic tests have been introduced; these two new tests can detect TB infection in patients by challenging peripheral blood cells with specific TB proteins. These assays measure the cellular immune response to these proteins. This minireview evaluates the new assays and compares them to the use of the TB skin test. The use of these new assays may have some advantages in detecting individuals with active tuberculosis. However, there is still a role for the use of the skin test, especially in young patients.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26018533      PMCID: PMC4519719          DOI: 10.1128/CVI.00199-15

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  40 in total

1.  'Management of a tuberculosis exposure in the immunocompromised setting - are the NICE guidelines adequate?'.

Authors:  Mary Jane O'Leary; Terry Markham O'Connor; Seamus O'Reilly
Journal:  Clin Med (Lond)       Date:  2013-12       Impact factor: 2.659

Review 2.  Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review.

Authors:  Alice Zwerling; Susan van den Hof; Jerod Scholten; Frank Cobelens; Dick Menzies; Madhukar Pai
Journal:  Thorax       Date:  2011-01-12       Impact factor: 9.139

Review 3.  Gamma interferon release assays for detection of Mycobacterium tuberculosis infection.

Authors:  Madhukar Pai; Claudia M Denkinger; Sandra V Kik; Molebogeng X Rangaka; Alice Zwerling; Olivia Oxlade; John Z Metcalfe; Adithya Cattamanchi; David W Dowdy; Keertan Dheda; Niaz Banaei
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

4.  Interferon gamma release assays and the NICE 2011 guidelines on the diagnosis of latent tuberculosis.

Authors:  Helen R Mujakperuo; Richard D Thompson; David R Thickett
Journal:  Clin Med (Lond)       Date:  2013-08       Impact factor: 2.659

5.  Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2000-06-09

6.  Evaluation of interferon-gamma release assays for the diagnosis of tuberculosis: an updated meta-analysis.

Authors:  Y Dai; Y Feng; R Xu; W Xu; W Lu; J Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-26       Impact factor: 3.267

7.  Community-based evaluation of immigrant tuberculosis screening using interferon γ release assays and tuberculin skin testing: observational study and economic analysis.

Authors:  Manish Pareek; Marion Bond; Jennifer Shorey; Suranjith Seneviratne; Margaret Guy; Peter White; Ajit Lalvani; Onn Min Kon
Journal:  Thorax       Date:  2012-06-12       Impact factor: 9.139

Review 8.  Tuberculosis in pregnancy: a review.

Authors:  Olabisi M Loto; Ibraheem Awowole
Journal:  J Pregnancy       Date:  2011-11-01

Review 9.  IFN-γ release assays in the diagnosis of latent tuberculosis infection among immunocompromised adults.

Authors:  Gil Redelman-Sidi; Kent A Sepkowitz
Journal:  Am J Respir Crit Care Med       Date:  2013-08-15       Impact factor: 30.528

10.  Cost-effectiveness of interferon-gamma release assay for entry tuberculosis screening in prisons.

Authors:  A Kowada
Journal:  Epidemiol Infect       Date:  2013-01-03       Impact factor: 4.434

View more
  6 in total

1.  Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients.

Authors:  Mi Ra Ryu; Min-Seung Park; Eun Hye Cho; Chul Won Jung; Kihyun Kim; Seok Jin Kim; Ha Young Oh; Wooseong Huh; Hye Ryoun Jang; Won-Jung Koh; Hye Yun Park; Young-Ho Kim; Dong Hyun Sinn; Jin-Oh Choi; Jae-Won Joh; Jong Man Kim; Sung Joo Kim; Jae Berm Park; Eun-Suk Kang
Journal:  J Clin Microbiol       Date:  2018-10-25       Impact factor: 5.948

2.  Evaluation of the RT-LAMP and LAMP methods for detection of Mycobacterium tuberculosis.

Authors:  Dandan Wu; Jiwen Kang; Baosheng Li; Dianxing Sun
Journal:  J Clin Lab Anal       Date:  2017-09-22       Impact factor: 2.352

3.  Two-Year Follow-up Study of Mycobacterium tuberculosis Antigen-Driven IFN-γ Responses and Macrophage sCD14 Levels After Tuberculosis Contact.

Authors:  Magdalena Druszczynska; Marcin Wlodarczyk; Grzegorz Kielnierowski; Malwina Kawka; Wieslawa Rudnicka
Journal:  Indian J Microbiol       Date:  2016-02-23       Impact factor: 2.461

4.  The effects of intradermal M. bovis and M. avium PPD test on immune-related mRNA and miRNA in dermal oedema exudates of water buffaloes (Bubalus bubalis).

Authors:  Carlotta Catozzi; Valentina Zamarian; Gabriele Marziano; Emanuela Dalla Costa; Alessandra Martucciello; Paola Serpe; Domenico Vecchio; Cristina Lecchi; Esterina De Carlo; Fabrizio Ceciliani
Journal:  Trop Anim Health Prod       Date:  2021-04-06       Impact factor: 1.559

5.  Is TB Testing Associated With Increased Blood Interferon-Gamma Levels?

Authors:  Aideen E Kennedy; Jim O'Mahony; Noel Byrne; John MacSharry; Riona G Sayers
Journal:  Front Vet Sci       Date:  2017-10-23

Review 6.  The Relevance of Genomic Epidemiology for Control of Tuberculosis in West Africa.

Authors:  Prince Asare; Adwoa Asante-Poku; Stephen Osei-Wusu; Isaac Darko Otchere; Dorothy Yeboah-Manu
Journal:  Front Public Health       Date:  2021-07-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.